Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99


Association of Differentiation-Related Gene-1 (DRG1) with Breast Cancer Survival and in Vitro Impact of DRG1 Suppression.

Baig RM, Sanders AJ, Kayani MA, Jiang WG.

Cancers (Basel). 2012 Jul 10;4(3):658-72. doi: 10.3390/cancers4030658.


Expression of membrane type-1 matrix metalloproteinase, MT1-MMP in human breast cancer and its impact on invasiveness of breast cancer cells.

Jiang WG, Davies G, Martin TA, Parr C, Watkins G, Mason MD, Mansel RE.

Int J Mol Med. 2006 Apr;17(4):583-90.


The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells.

Zia MK, Rmali KA, Watkins G, Mansel RE, Jiang WG.

Int J Mol Med. 2007 Oct;20(4):605-11.


Claudin-5 is involved in breast cancer cell motility through the N-WASP and ROCK signalling pathways.

Escudero-Esparza A, Jiang WG, Martin TA.

J Exp Clin Cancer Res. 2012 May 4;31:43. doi: 10.1186/1756-9966-31-43.


Targeting matrilysin and its impact on tumor growth in vivo: the potential implications in breast cancer therapy.

Jiang WG, Davies G, Martin TA, Parr C, Watkins G, Mason MD, Mokbel K, Mansel RE.

Clin Cancer Res. 2005 Aug 15;11(16):6012-9.


Drg1 expression in 131 colorectal liver metastases: correlation with clinical variables and patient outcomes.

Shah MA, Kemeny N, Hummer A, Drobnjak M, Motwani M, Cordon-Cardo C, Gonen M, Schwartz GK.

Clin Cancer Res. 2005 May 1;11(9):3296-302.


Up-regulation of METCAM/MUC18 promotes motility, invasion, and tumorigenesis of human breast cancer cells.

Zeng GF, Cai SX, Wu GJ.

BMC Cancer. 2011 Mar 30;11:113. doi: 10.1186/1471-2407-11-113.


Clinical implications of the influence of Ehm2 on the aggressiveness of breast cancer cells through regulation of matrix metalloproteinase-9 expression.

Yu H, Ye L, Mansel RE, Zhang Y, Jiang WG.

Mol Cancer Res. 2010 Nov;8(11):1501-12. doi: 10.1158/1541-7786.MCR-10-0186. Epub 2010 Oct 5.


Identification and validation of genes with expression patterns inverse to multiple metastasis suppressor genes in breast cancer cell lines.

Marino N, Collins JW, Shen C, Caplen NJ, Merchant AS, Gökmen-Polar Y, Goswami CP, Hoshino T, Qian Y, Sledge GW Jr, Steeg PS.

Clin Exp Metastasis. 2014 Oct;31(7):771-86. doi: 10.1007/s10585-014-9667-0. Epub 2014 Aug 3.


CD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activity.

Montgomery N, Hill A, McFarlane S, Neisen J, O'Grady A, Conlon S, Jirstrom K, Kay EW, Waugh DJ.

Breast Cancer Res. 2012 May 23;14(3):R84.


Knockdown of human antigen R reduces the growth and invasion of breast cancer cells in vitro and affects expression of cyclin D1 and MMP-9.

Yuan Z, Sanders AJ, Ye L, Wang Y, Jiang WG.

Oncol Rep. 2011 Jul;26(1):237-45. doi: 10.3892/or.2011.1271. Epub 2011 Apr 18.


The expression and prognostic value of ROCK I and ROCK II and their role in human breast cancer.

Lane J, Martin TA, Watkins G, Mansel RE, Jiang WG.

Int J Oncol. 2008 Sep;33(3):585-93.


A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms.

van Belzen N, Dinjens WN, Diesveld MP, Groen NA, van der Made AC, Nozawa Y, Vlietstra R, Trapman J, Bosman FT.

Lab Invest. 1997 Jul;77(1):85-92.


A role for WISP2 in colorectal cancer cell invasion and motility.

Frewer KA, Sanders AJ, Owen S, Frewer NC, Hargest R, Jiang WG.

Cancer Genomics Proteomics. 2013 Jul-Aug;10(4):187-96.


Hypochlorite-induced oxidative stress elevates the capability of HDL in promoting breast cancer metastasis.

Pan B, Ren H, Lv X, Zhao Y, Yu B, He Y, Ma Y, Niu C, Kong J, Yu F, Sun WB, Zhang Y, Willard B, Zheng L.

J Transl Med. 2012 Mar 30;10:65. doi: 10.1186/1479-5876-10-65.


Protein tyrosine phosphatase kappa (PTPRK) is a negative regulator of adhesion and invasion of breast cancer cells, and associates with poor prognosis of breast cancer.

Sun PH, Ye L, Mason MD, Jiang WG.

J Cancer Res Clin Oncol. 2013 Jul;139(7):1129-39. doi: 10.1007/s00432-013-1421-5. Epub 2013 Apr 4.


Importance of osteoprotegrin and receptor activator of nuclear factor κB in breast cancer response to hepatocyte growth factor and the bone microenvironment in vitro.

Owen S, Sanders AJ, Mason MD, Jiang WG.

Int J Oncol. 2016 Mar;48(3):919-28. doi: 10.3892/ijo.2016.3339. Epub 2016 Jan 15.

Supplemental Content

Support Center